OVERT GASTROINTESTINAL-BLEEDING IN THE COURSE OF CHRONIC LOW-DOSE ASPIRIN ADMINISTRATION FOR SECONDARY PREVENTION OF ARTERIAL OCCLUSIVE DISEASE
- 1 April 1990
- journal article
- research article
- Vol. 85 (4) , 408-411
Abstract
We describe 13 patients who developed erosive gastritis with overt gastrointestinal bleeding while receiving 75-250 mg nonbuffered aspirin per day for the secondary prevention of cardiac or cerebrovascular events. The bleeding occurred despite good initial tolerance to aspirin for several months or years. All patients were elderly and had severe atherosclerotic cardiovascular disease. Our data suggest that, contrary to common belief, very low doses of nonbuffered aspirin are attendant with clinically apparent gastrointestinal complications.This publication has 12 references indexed in Scilit:
- Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesicsArchives of internal medicine (1960), 1988
- Randomised trial of prophylactic daily aspirin in British male doctorsBMJ, 1988
- Aspirin and the StomachAnnals of Internal Medicine, 1986
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Gastric adaptation occurs with aspirin administration in manDigestive Diseases and Sciences, 1983
- DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESISThe Lancet, 1981
- ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTIONThe Lancet, 1979
- Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin TherapyAnnals of Internal Medicine, 1979